Objective: A known HIV status is the most important step in preventing mother-to-child transmission of HIV and screening for HIV is recommended by German prenatal guidelines. In our study, we wanted to ascertain the prevalence of HIV-testing in a pregnant inner-city cohort.
Methods: Prenatal records of 279 women were prospectively studied, and the testing confirmed with the prenatal care providers.
Results: 82.4 % of the patients had been tested for HIV during pregnancy. The test was refused by 4.0 % of the women. Contrary to current guidelines, in more than half of the cases documentation of the test or the result was found in the women's prenatal care papers.
Conclusions: Even though a large majority of pregnant women are screened for HIV, the rates of testing need to be increased. Education of patients and providers as well as changing to the "opt-out" approach used in other countries may prevent unnecessary mother-to-child transmission of HIV.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00404-013-2744-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Inequitable gender norms and its associated factors among university students in southern Ethiopia: a cross-sectional study, 2022.
Front Public Health
January 2025
CDC Project Regional HIV Case Surveillance Coordinator, Public Health Emergency Management Directorate, South Ethiopia Region Health Bureau Public Health Institute, Jinka, Ethiopia.
Background: Gender defined as the socially constructed roles, behaviors, activities, and characteristics that society deems appropriate for men, women, and other gender identities. Inequitable gender norms promote male dominance and aggressiveness while portraying women as being subservient. Ensuring equitable gender norms is a prerequisite for achieving gender equality in a society.
View Article and Find Full Text PDFIdentifying psychosocial predictors and developing a risk score for preterm birth among Kenyan pregnant women.
BMC Pregnancy Childbirth
January 2025
Department of Epidemiology, University of Washington, 3980 15th Ave NE, Box 351619, Seattle, WA, 98195, USA.
Background: Preterm birth (PTB) is a leading cause of neonatal mortality, particularly in sub-Saharan Africa where 40% of global neonatal deaths occur. We identified and combined demographic, clinical, and psychosocial correlates of PTB among Kenyan women to develop a risk score.
Methods: We used data from a prospective study enrolling HIV-negative women from 20 antenatal clinics in Western Kenya (NCT03070600).
Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084.
J Int AIDS Soc
January 2025
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Introduction: Long-acting injectable cabotegravir (CAB-LA) for pre-exposure prophylaxis significantly reduced HIV acquisition in HPTN 084. We report on the safety and CAB-LA pharmacokinetics in pregnant women during the blinded period of HPTN 084.
Methods: Participants were randomized 1:1 to either active cabotegravir (CAB) plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) placebo or active TDF/FTC plus CAB placebo.
CROI 2024: The Challenges of Sustained Viral Suppression, Advanced HIV Disease, and Ending the HIV Epidemic Targets.
Top Antivir Med
August 2024
New York Blood Center, New York, New York, USA.
Data on the HIV care cascade demonstrated challenges in achieving Ending the HIV Epidemic (EHE) targets across all 18 EHE focus metropolitan areas, but innovative adherence interventions using point-of-care tenofovir testing and motivational interviewing support care cascade outcomes in Namibia and South Africa, respectively. Data on treatment with long-acting injectable (LAI) antiretroviral therapy (ART) demonstrated high acceptability, retention, and virologic suppression including in groups that were not well represented in clinical trials including persons born female and persons with detectable viral loads. The adjuvanted hepatitis B vaccine appeared to be safe and appeared to be superior to conventional hepatitis B vaccines in persons with HIV (PWH) who were prior nonresponders to the hepatitis B vaccine.
View Article and Find Full Text PDFRisk of adverse birth outcomes and birth defects among women living with HIV on antiretroviral therapy and HIV-negative women in Uganda, 2015-2021.
J Acquir Immune Defic Syndr
January 2025
Makerere University - Johns Hopkins University Research Collaboration, Kampala, Uganda.
Introduction: We assessed the risk of adverse pregnancy and birth outcomes and birth defects among women living with HIV (WLHIV) on antiretroviral therapy (ART) and HIV-negative women.
Methods: We analyzed data on live births, stillbirths, and spontaneous abortions during 2015-2021 from a hospital-based birth defects surveillance system in Kampala, Uganda. ART regimens were recorded from hospital records and maternal self-reports.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!